Skip to main content
. 2019 Sep 26;71(4):1080–1088. doi: 10.1093/cid/ciz928

Table 3.

Association Between Tuberculosis and Diabetes Mellitus or Impaired Glucose Regulation at Enrollment and 3-Month Follow-up

Enrollment Follow-up
Characteristic Overall (N = 850) Participants With HIV (n = 541) Partcipants Without HIV (n = 309) Overall (N = 639) Participants With HIV (n = 399) Participants Without HIV (n = 240)
IGR
 No IGR 1.0 1.0 1.0 1.0 1.0 1.0
 IGR by HbA1c 1.6 (1.1–2.3) 1.5 (1.0–2.3) 2.2 (1.2–4.1) 0.6 (.4–1.1) 0.6 (.3–1.2) 0.8 (.3–2.0)
 IGR by FPG 0.9 (.5–1.5) 1.2 (.6–2.2) 0.4 (.1–1.2) 1.2 (.6–2.3) 0.8 (.3–2.2) 1.6 (.6–4.2)
 IGR by combined test (HbA1c or FPG) 2.3 (1.6–3.3) 2.4 (1.51–3.8) 2.3 (1.1–4.7) 0.84 (.53–1.36) 0.77 (.41–1.16) 1.10 (.47–2.57)
Combining preexisting DM and newly diagnosed DM
 No DM 1.0 1.0 1.0 1.0 1.0 1.0
 DM by HbA1c 2.4 (1.2–4.6) 2.4 (1.0–5.9) 2.2 (.7–6.3) 2.1 (.8–5.3) 2.5 (.5–11.8) 1.8 (.5–6.7)
 DM by FPG 2.3 (1.0–5.9) 2.9 (.7–12.2) 1.9 (.7–6.4) 2.8 (.9–8.4) 9.8 (.9–106.6) 1.6 (.4–6.5)
 DM by combined test (HbA1c or FPG) 2.8 (1.5–5.3) 2.4 (1.0–5.3) 3.5 (1.2–9.8) 3.3 (1.5–7.3) 3.8 (1.2–12.3) 3.5 (1.1–11.0)
Newly diagnosed DM only
 No DM 1.0 1.0 1.0 1.0 1.0 1.0
 DM by HbA1c 1.6 (.7–3.6) 1.7 (1.0–2.9) 1.0 (.1–7.6) 1.5 (.3–7.0) 1.3 (.2–8.1) 2.4 (.1–49.1)
 DM by FPG 1.7 (.3–8.8) 9.2 (.9–97.0) 2.2 (1.0–4.7) 3.0 (.2–40.5) a 2.0 (.6–7.2)
 DM by combined test (HbA1c or FPG) 2.2 (1.0–4.7) 1.6 (.7–4.0) 3.6 (.7–19.5) 2.0 (.6–7.2) 1.6 (.3–7.3) 4.5 (.3–59.9)
Preexisting DM only
 No DM 1.0 1.0 1.0 1.0 1.0 1.0
 DM 3.7 (1.5–9.1) 6.3 (1.3–30.8) 3.1 (.9–10.1) 4.0 (1.6–10.1) 9.3 (1.7–49.0) 3.0 (.9–10.1)

Data are presented as odds ratio (95% confidence interval). Bold text represents significant associations. Reference group for the associations: patients with no DM or IGR. All odds ratios were adjusted for sex, age, household size, income, hypertension (baseline), previous miner, previous prisoner, marital status, work status, and HIV-1 status.

Abbreviations: DM, diabetes mellitus; FPG, fasting plasma glucose; HbA1c, glycated hemoglobin; HIV, human immunodeficiency virus; IGR, impaired glucose regulation.

aInsufficient data to perform test-specific analysis.